Publication & Citation Trends
Publications
0 total
p16 Represses DNA Damage Repair via a Novel Ubiquitin-Dependent Signaling Cascade OA
Cited by 24
Semantic Scholar
IDO1 Inhibition Overcomes Radiation-Induced "Rebound Immune Suppression" by Reducing Numbers of IDO1-Expressing Myeloid-Derived Suppressor Cells in the Tumor Microenvironment.
Cited by 44
Semantic Scholar
Indoleamine 2,3-dioxygenase 1 inhibition targets anti-PD1-resistant lung tumors by blocking myeloid-derived suppressor cells. OA
Cited by 60
Semantic Scholar
Suppression of Type I IFN Signaling in Tumors Mediates Resistance to Anti-PD-1 Treatment That Can Be Overcome by Radiotherapy. OA
Cited by 204
Semantic Scholar
BAP1 Is a Novel Target in HPV-Negative Head and Neck Cancer OA
Cited by 27
Semantic Scholar
Targeting anti-PD1-resistant tumors via indoleamine 2,3-dioxygenase 1 (IDO1) inhibition.
Cited by 3
Semantic Scholar
Suppression of Major Histocompatibility Complex (MHC) Class I and II Mediates Resistance to Anti-PD-1 in Lung Adenocarcinoma Tumors That Can Be Overcome by Radiation Therapy.
Cited by 4
Semantic Scholar
Using Radiation Therapy to Improve CAR T-Cell Targeting of Solid Tumors OA
Cited by 2
Semantic Scholar
Abstract 569: MicroRNA-mediated resistance to anti-PD1 therapy in lung cancer
Cited by 0
Semantic Scholar
PDL1 Regulation by p53 via miR-34 OA
Cited by 639
Semantic Scholar
Research Topics
Cancer-related Molecular Pathways
(18)
Cancer Immunotherapy and Biomarkers
(12)
Cancer, Hypoxia, and Metabolism
(11)
Immunotherapy and Immune Responses
(9)
DNA Repair Mechanisms
(8)
Affiliations
The University of Texas MD Anderson Cancer Center
Mirna Therapeutics (United States)
The Ohio State University